ArticleNature cancer2022

LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer.

Iván Pérez-Núñez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.